ZYBT

Conviction 53HealthcareScan · Mon, Aug 10, 2026

ZYBT$1.83-3.17%

ResistanceSupportVol 14

Vol MA14 8.44M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Zhengye Biotechnology Holding LtdDrug Manufacturers - Specialty & Genericwww.jlzybio.com ↗

Price1.83

Change-3.17%

Gap-2.38%

Rel volume0.00×

Avg volume16.1M

Avg $ vol84.36M

SMA 201.81

SMA 501.19

SMA 2001.28

Price vs 50+53.31%

Price vs 200+43.30%

MA stackmixed

50/200 cross—

Supertrenddown · 3.27

RSI (14)52

MACD hist-0.01

MACD crossbear · 9d

Stoch %K / %D23 / 20

ADX (14)53

+DI / −DI53 / 6

RSI divergence—

MACD divergence—

ATR %+45.18%

ADR %33.37%

52w high12.67

52w low0.6462

From 52w high-85.55%

Above 52w low+183.19%

New 52w highNo

SqueezeOff

Bollinger width336.12%

%B0.50

Donchian pos15.48%

Donchian high8.01

Donchian low0.6980

AVWAP (52w high)4.03

vs AVWAP high-54.60%

AVWAP (52w low)4.18

vs AVWAP low-56.23%

OBV trendUp

Chaikin MF (20)0.35

Today vs 20d0.00×

Avg vol (14d)8.44M

Avg vol (20d)16.1M

Avg $ vol (20d)84.36M

Market cap86.73M

RS 3m (vs SPY)+87.63%

RS 6m (vs SPY)+137.89%

RS line new highNo

Trend template4/8

Technical rank88.0

1 week+37.59%

1 month+134.62%

3 months+92.73%

6 months+117.75%

1 year-67.84%

YTD+61.95%

P/E—

P/B2.43

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.02

Current1.14

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional0.92%

Ent. value84.94M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryDrug Manufacturers - Specialty & Generic

ExchangeNasdaq

Shares out—

Employees269

ListedTue, Jan 7, 2025

Free float4.15M

Float %8.8%

Short interest57.36K

Days to cover0.6d

Short volume29.8%

Squeeze score6 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank88.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.15

Support0.6261

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in ZYBT

All disclosures →

No recent disclosed trades by Congress in ZYBT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZYBT

No recent insider (Form 4) filings in ZYBT. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ZYBT · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.